Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01371890 · ClinicalTrials.gov registry record
Mechanisms and Treatment of Intradialytic Hypertension - Sodium
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT01371890: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT01371890 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01371890 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the role of dialysate exposure and fluid removal during hemodialysis in the pathophysiology of intradialytic hypertension.
Primary Outcome
Differences in blood pressure during hemodialysis between treatments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-08 |
What the finished NCT01371890 record still lists
NCT01371890 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01371890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01371890 about?
NCT01371890 is a clinical study titled "Mechanisms and Treatment of Intradialytic Hypertension - Sodium". The purpose of this study is to determine the role of dialysate exposure and fluid removal during hemodialysis in the pathophysiology of intradialytic hypertension.
What is the current status of trial NCT01371890?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2011-05. Estimated completion is 2012-08.
Who is sponsoring clinical trial NCT01371890?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia